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1. Abstract
Background: Current concepts of Attention-Deficit/Hyperactivity Disorder (ADHD) emphasize the role of
higher-order cognitive functions and reinforcement processes attributed to structural and biochemical anomalies
in cortical and limbic neural networks innervated by the monoamines, dopamine, noradrenaline and serotonin.
However, these explanations do not account for the ubiquitous findings in ADHD of intra-individual performance
variability, particularly on tasks that require continual responses to rapid, externally-paced stimuli. Nor do they
consider attention as a temporal process dependent upon a continuous energy supply for efficient and consistent
function. A consideration of this feature of intra-individual response variability, which is not unique to ADHD but
is also found in other disorders, leads to a new perspective on the causes and potential remedies of specific
aspects of ADHD.
The hypothesis: We propose that in ADHD, astrocyte function is insufficient, particularly in terms of its
formation and supply of lactate. This insufficiency has implications both for performance and development: H1)
In rapidly firing neurons there is deficient ATP production, slow restoration of ionic gradients across neuronal
membranes and delayed neuronal firing; H2) In oligodendrocytes insufficient lactate supply impairs fatty acid
synthesis and myelination of axons during development. These effects occur over vastly different time scales:
those due to deficient ATP (H1) occur over milliseconds, whereas those due to deficient myelination (H2) occur
over months and years. Collectively the neural outcomes of impaired astrocytic release of lactate manifest
behaviourally as inefficient and inconsistent performance (variable response times across the lifespan, especially
during activities that require sustained speeded responses and complex information processing).
Testing the hypothesis: Multi-level and multi-method approaches are required. These include: 1) Use of
dynamic strategies to evaluate cognitive performance under conditions that vary in duration, complexity, speed,
and reinforcement; 2) Use of sensitive neuroimaging techniques such as diffusion tensor imaging, magnetic
resonance spectroscopy, electroencephalography or magnetoencephalopathy to quantify developmental changes
in myelination in ADHD as a potential basis for the delayed maturation of brain function and coordination, and
3) Investigation of the prevalence of genetic markers for factors that regulate energy metabolism (lactate,
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Behavioral and Brain Functions 2006, 2:30 http://www.behavioralandbrainfunctions.com/content/2/1/30glutamate, glucose transporters, glycogen synthase, glycogen phosphorylase, glycolytic enzymes), release of
glutamate from synaptic terminals and glutamate-stimulated lactate production (SNAP25, glutamate receptors,
adenosine receptors, neurexins, intracellular Ca2+), as well as astrocyte function (α1, α2 and β-adrenoceptors,
dopamine D1 receptors) and myelin synthesis (lactate transporter, Lingo-1, Quaking homolog, leukemia inhibitory
factor, and Transferrin).
Implications of the hypothesis: The hypothesis extends existing theories of ADHD by proposing a
physiological basis for specific aspects of the ADHD phenotype – namely frequent, transient and impairing
fluctuations in functioning, particularly during performance of speeded, effortful tasks. The immediate effects of
deficient ATP production and slow restoration of ionic gradients across membranes of rapidly firing neurons have
implications for daily functioning: For individuals with ADHD, performance efficacy would be enhanced if
repetitive and lengthy effortful tasks were segmented to reduce concurrent demands for speed and accuracy of
response (introduction of breaks into lengthy/effortful activities such as examinations, motorway driving,
assembly-line production). Also, variations in task or modality and the use of self- rather than system-paced
schedules would be helpful. This would enable energetic demands to be distributed to alternate neural resources,
and energy reserves to be re-established. Longer-term effects may manifest as reduction in regional brain volumes
since brain areas with the highest energy demand will be most affected by a restricted energy supply and may be
reduced in size. Novel forms of therapeutic agent and delivery system could be based on factors that regulate
energy production and myelin synthesis. Since the phenomena and our proposed basis for it are not unique to
ADHD but also manifests in other disorders, the implications of our hypotheses may be relevant to understanding
and remediating these other conditions as well.
2. Background
Attention-Deficit/Hyperactivity Disorder (ADHD) is a
highly heritable and heterogeneous condition with a
widespread prevalence [1]. It often persists into adult-
hood with deleterious effects on educational, social, and
occupational outcomes [2,3]. ADHD is defined by persist-
ing, developmentally inappropriate, cross-situational,
impairing levels of inattention, impulsiveness, and hyper-
activity [4]. Our hypothesis focuses on a common observ-
able feature of ADHD, marked moment-to-moment
fluctuation in task performance [5-9]. Yet this ubiquitous
phenomenon has been viewed as uninteresting random
noise and ignored in the ADHD research field almost
entirely until recently, when it was proposed as an aetio-
logically important characteristic requiring systematic
analysis [10]. Behavioural and performance fluctuations
are displayed over multiple time scales, but our primary
interest here are with those that occur over seconds, rather
than hours or days.
The genesis of this type of intra-individual performance
variability (variability during continual responding to
externally-paced stimuli) remains unknown. We propose
that it arises from inefficient and inconsistent neuronal
transmission of information, due to a deficient energy
supply – lactate production – by the major non-neuronal
component of the central nervous system (CNS), the
astrocyte [11-13]. Astrocytes play a critical role in provid-
ing energy via lactate to rapidly firing neurons. Astrocytes
can also provide lactate to oligodendrocytes, which is
used as a substrate for myelin synthesis by oligodendro-
cytes [14], and thus enables rapid neurotransmission. The
presence of receptors for the major brain neurotransmit-
ters on astrocytes adds to the robust evidence for their
direct involvement in neurotransmission [15-18]. Given
that performance variability is not unique to ADHD but
rather a common and unifying feature of several disor-
ders, such as Traumatic Brain Injury, Schizophrenia, Nar-
colepsy, Phenylketonuria (PKU), as well as ADHD, we do
not propose such variance as a specific marker of ADHD.
Rather we argue that intra-individual response variability
may be an important index of the efficiency of neural sig-
nalling which, in turn, is dependent on neurobiological
regulation of brain function (e.g. factors that regulate the
energy supply to neurons). Also, we suggest that it may
account for a substantial proportion of the variance in
performance of executive function tasks such that poor
task performance may not reflect impaired executive func-
tion per se, but rather an admixture of poor neurobiologi-
cal regulation of the external physiological environment
of rapidly firing neurons as well as slowed processing
speed arising from inadequately myelinated neurons, par-
ticularly those involved in working memory [19].
First we summarize the evidence for the transient fluctua-
tions in task performance of individuals with ADHD, and
the inadequacy of current explanations to account for the
short time scales involved. Our hypothesis, introduced
initially by Todd and Botteron [13], is then elaborated
with evidence for important elements of the theory.
Finally we outline strategies for testing the hypothesis and
discuss its theoretical and clinical significance.Page 2 of 25
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2.1.1 Intra-individual behavioural variability
We propose that increased intra-individual behavioural
variability in continual responses to rapid, externally-
paced stimuli are related to other factors than those caus-
ing increased variability in free-operant, non-externally
paced tasks [8,9,20]. The former is timed by objective
clock time, the latter by behavioural events not necessarily
highly correlated with objective time. We define intra-
individual variability as short-term fluctuations in the per-
formance of an individual over a time-scale of seconds. It
is differentiated from systematic and longer-lasting time-
related changes in task performance due to practice, learn-
ing, developmental growth, or to remission or progres-
sion of a clinical condition or disease. This intra-
individual variability will be the cause of inter-task varia-
bility. While not central in ADHD research, intra-individ-
ual response variability has been used as a primary
dependent variable in research in normal ageing and in
neurological populations [21-27]. Evidence that individu-
als with mild dementia exhibit greater intra-individual
variability than both healthy adults and those with arthri-
tis suggests that it reflects neurological compromise rather
than deterioration of general health [22,28]. Moreover,
findings from studies incorporating structural or func-
tional human brain mapping methods indicate that intra-
individual variability is not simply a sequela of general
brain dysfunction, but is likely related to the functioning
of neural circuits that engage the prefrontal cortex, partic-
ularly the dorsolateral areas [25,29,30]. Behavioural find-
ings indicate that intra-individual response variability is a
strong predictor of success [30], suggesting that poor per-
formance on control tasks like Go-No-Go, inhibition ver-
sions of continuous performance tests (CPT), and stop-
signal task may reflect problems in response variability
rather than poor inhibitory control per se.
Prior to summarizing the empirical research on intra-indi-
vidual variability in ADHD, a comment is warranted on
the various approaches to its measurement. The most
common method of characterizing variability in response
or reaction times (both denoted here by RT) consists of a
single-point estimate of the standard deviation (SD)
around the mean reaction time (MRT) for each individual
(ISD). This method has the advantage of simplicity, but
because it aggregates response indices across time inter-
vals, it conflates effects due to practice, learning, overall
speed of responding, and randomness, with possible sys-
tematic periodic fluctuations in response times. Most
importantly, response variability is usually strongly corre-
lated with MRT [31]; computation of an intra-individual
coefficient of variation (ICV = ISD/MRT) controls to some
extent for the individual's overall speed of response. Two
other measures capitalize to some extent on information
that may be derived from serial analysis of response, but
do not permit examination of potential periodicities
within the moment-to-moment fluctuations in perform-
ance. Consecutive variability (CONV = √(∑(RTi - RTi-1)2/
(n - 1)), where I = trial number, n = number of trials, √ =
square root) provides a measure of local unpredictability
(trial-to-trial variability) as well as controlling overall
MRT. Autocorrelations (correlations between consecutive
or subsequent observations) measure the extent of linear
association between one response and subsequent
responding, thereby providing insights into the consist-
ency and predictability of behaviour [8,25]. Another
approach has been to fit trial-by-trial RT data to the ex-
Gaussian distribution, which provides parameters that
may be related to more theoretically based distributions,
such as the Wald [32]. This method permits determina-
tion of whether the increase in intra-individual RT varia-
bility in ADHD is a general phenomenon occurring across
the whole RT distribution, or reflects a specific variability-
producing process, such as attentional lapses, restricted to
the tail at the slow end of the distribution [27]. The ex-
Gaussian analysis delivers two measures of variability:
one from the fast, Gaussian portion of the distribution,
and one from the slow exponential tail [31]. In normal
development and ageing, age-related change in intra-indi-
vidual variability throughout childhood affects the distri-
bution as a whole, whereas in adulthood, differences in
variability appears to be due to factors influencing prima-
rily the slow end of the RT distribution, such as atten-
tional lapses [22,33].
The fast Fourier transform, which measures the power of
periodic changes at different temporal frequencies, per-
mits an assessment of periodicity over time [34]. Any peri-
odically recurring patterns of responding within the RT
series are manifest as peaks of power at particular frequen-
cies.
2.1.2 Intra-individual variability in ADHD
Significant and reliable differences in the speed and varia-
bility of responses have been documented between
ADHD and comparison groups across a wide variety of
neuropsychological tasks. Increased variability is seen in
tasks requiring continual responses to rapid, externally-
paced stimuli as well as in "free-operant" tasks without
such a requirement. Recent studies of South African chil-
dren from 7 ethnic groups and Norwegian children, using
a computerized game-like free-operant task [8,9], showed
significantly lower predictability of responding in ADHD
than in non-ADHD groups. Predictability of response
location and timing were measured in terms of variance
explained by autocorrelations. Interestingly, in the free-
operant task without externally-paced stimuli, response
location – but not response timing – was a sensitive
behavioural measure. In tasks requiring continual
responses to rapid, externally-paced stimuli, however,Page 3 of 25
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ability in response times and are often found to respond
more slowly and less accurately than their typically devel-
oping peers [6]. These performance differences have been
found on the stop-signal task [35-38], a variety of CPT
[39-41], time perception, time reproduction and motor
timing tests [42-45], and visuomotor preparation tests
[46]. Notably, a recent psychometric analysis of several
measures of intra-individual variability (ISD, ICV, CONV)
as well as measures of central tendency and shape of the
reaction time distribution derived from children's per-
formance of four different neuropsychological tasks (stop
signal task, CPT, Go-No-Go, n-back working memory
task) yield two important findings [47]. First, measures of
intra-individual variability best discriminated between
the ADHD and control groups; second, intra-individual
variability appeared to be a unitary construct in ADHD
(individuals with high variability on one task tended to
have high variability on other tasks).
Poorer performance on neuropsychological tasks in
ADHD is typically interpreted as evidence of executive
function deficits, an interpretation that is based on slower
and less accurate responses averaged across time. Accom-
panying group differences in intra-individual response
variability are typically ignored – or, worse, become a nui-
sance parameter that keeps the inferential statistics from
achieving significance. For example, the interpretation
"poor inhibitory control" is commonly based on slower
RTs to the stop signal or more commission errors in the
CPT. Yet, it is often intra-individual variability in RT that
correlates with the behavioural symptoms of ADHD, not
the mean of the criterion variable [38,40,48,49].
Response variability correlates more strongly and reliably
with ratings of ADHD symptoms compared to commis-
sion errors or other outcome measures on the CPT in a
large epidemiological sample [40] and compared with
stop signal reaction time (i.e. index of inhibitory control)
in a large twin sample [38] or average response speed in a
community sample of typically developing children [48].
Application of the ex-Gaussian model to RT data indicates
that the greater response time variability in individuals
with ADHD is most evident in the slow tail [50-52]: There
appears to be some variability-producing process, such as
momentary attentional lapses, that affects the slow RTs
[50]. Recent evidence from Fourier analysis found that
children with ADHD showed increased variability at all
parts of the RT spectrum [53], consistent with Williams et
al[54] who showed that intra-individual response varia-
bility in the fast tail of the distribution is distinct from that
found in the slow tail. However, there is significantly
(50%) more intra-individual variability in reaction time
of individuals with ADHD at a modal frequency of
around 0.05 Hz, indicative of lapses of attention 2 to 4
times per minute [53].
Variability is increased at all parts of the distribution [53]
which is consistent with Williams et al. [54] who showed
that that intra-individual response variability in the fast
tail of the distribution is distinct from that found in the
slow tail.
Intra-individual variability in response time has been pro-
posed as a possible endophenotype with the potential to
index genetic vulnerability to ADHD [10,55]. Further sup-
port for this proposition comes from two molecular
genetic studies that report associations between the 10-
repeat risk allele within the dopamine transporter gene
(DAT1) and response variability in ADHD [56,57]. The
dopamine transporter is the main site of action of methyl-
phenidate, which reduces intra-individual response varia-
bility in ADHD [35,53,58].
2.1.2.1 A theoretical model
The above models provide statistics descriptive of the
data. In order to better constrain our hypotheses by data,
we also develop a model of the cascade of energetic
resources that we posit in H1. That supply chain has many
similarities to hydraulic flow through n reservoirs [59],
with the decay into the last nth state being analogous to
the repletion of glutamate in the vesicles. Our hypothesis
H1 predicts that the decreased efficiency in energy trans-
port and glutamate restaging, which we posit to be charac-
teristic of ADHD, will cause slower repletion, and entail
larger values for the time constants that measure the mean
occupancy times at each energetic stage. To simplify the
model in light of available data, we assume equal time-
constants for each stage. This model predicts a gamma dis-
tribution of the time required for the energy level at the
last stage to reach the threshold necessary to support a
response.
The model has two parameters: the number of candidate
stages (n), and their average time constants (τ). The
gamma resembles the familiar ex-Gaussian distribution,
and provides a good description of reaction-time data.
Leth-Steensen, Elbaz and Douglas [52] compared the per-
formance of 17 ADHD boys off medication, with a mean
age of 11 years, with 18 age-matched control boys and ten
7 year-old boys, on a four-choice reaction-time task. Four
warning circles were presented on a screen for 2, 4, or 8 s
fore periods, followed by a change in the colour of one to
yellow. The boys were to press a key corresponding to the
changed stimulus. The authors fit ex-Gaussian densities to
the observed distributions, and also reported the mean
(μ) and variance (σ2) of the RT distributions. From those,
the parameters of the gamma model may be deduced: n =
μ2/σ2 and τ = σ2/μ. This analysis imputed n = 6 stages forPage 4 of 25
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tify precisely which energetic processes correspond to
these stages, but does indicate that there is a greater depth
of resources available for the control group. As predicted,
the processes are slower for ADHD, with time constants τ
= 141, 152, and 171 ms for the 2 s, 4 s, and 8 s intervals,
compared with τ = 39, 40, and 44 ms for controls. Hold-
ing parameters at these stipulated values, the gamma
model recovered the statistics describing the data, as
shown in Figure 1. The young control boys had interme-
diate parameters (n = 10 and τ = 40, 117, and 120 ms;
their data are omitted from Figure 1 to emphasize the key
comparison). The index of skewness of the gamma
depends only on the number of stages, being 2n-1/2 = 0.50
for controls and 0.82 for ADHD. This substantial increase
in skewness is consistent with the differential increase in
long response times for ADHD, and causes the larger var-
iance seen in reaction times for this condition [60].
According to our model, the increase is explained by the
slower replenishment in a cascade of energy reservoirs in
ADHD individuals compared to controls.
The model is simplistic in that it assumes a common
period (τ) for energetic processes that operate on multiple
time-scales, with some processes in parallel, as shown in
Figure 2. Comparison with other models, such as extreme-
value distributions which also could tell a revealing story
about the latent processes, awaits adequate data. More
informative trial-by-trial analyses (e.g., [53]) will yield the
fractal patterns of latencies first described by Hurst for
analogous hydraulic systems [61], and found in reaction
time distributions of normal subjects by Gilden [62]. It
will require such detailed analyses to further resolve our
hypothetical map between energy reservoirs and perform-
ance.
2.1.3 Fluctuations in attentional processing and performance
Transient fluctuations have also been revealed in recent
studies using innovative methods to capture shifts in
attentional processing within relatively short time-scales,
ranging from milliseconds to minutes. For example, rapid
serial visual presentation (RSVP) paradigms such as the
attentional blink design permit evaluation of temporal
characteristics of information processing within a time-
scale of milliseconds [63,64]. In this paradigm a stream of
stimuli is presented briefly (100 ms) in the same location
and in rapid succession (e.g., 10/s) and subjects are
required to detect two targets in the stream. When the tar-
gets are presented within about 500 ms of one another,
detection of the second target is impaired – a phenome-
non termed the "attentional blink". Children and adults
with ADHD and highly impulsive adolescents have been
found to show a larger and more protracted attentional
blink than their non-ADHD peers, suggesting less efficient
attentional processing and/or more rapid depletion of
processing resources [64-66].
Transient fluctuations in attentional state over a some-
what longer time-scale (30 s periods) have been demon-
strated by means of error analysis on computerized CPT
coupled with an infra-red motion analysis system. Analy-
sis of attentional states over a period of 30-s revealed that
children with ADHD exhibit many more shifts in atten-
tion states and spend much less time in an on-task atten-
tion state than their peers [67]. Fidgetiness, as detected by
the motion-analysis system, was found to be related to the
percent of time spent in the 'distracted' attentional state,
in which the children's awareness of the relevant stimuli
was diminished. These measures of attentional state pro-
vided more robust indicators of the performance differ-
ences between children with ADHD and comparison
children than did the traditional time-averaged CPT sum-
mary measures of error rates, latency and variability [67].
Fidgetiness, that most public characteristic of ADHD,
might be a by-product of fatigue of relevant neuronal cir-
cuits, and a search for new ones to engage.
2.1.4 Drug effects on intra-individual variability and attentional 
fluctuations
Reaction time variability is reduced with appropriate
monetary reward [45], but such rewards are not differen-
tially effective for children with ADHD. The reason for this
may be that reinforcers may be less effective for tasks
requiring continual responses to rapid, externally-paced
stimuli than for subject-paced (free-operant) responding
[68]. The reason for this is probably that reinforcers work
on free-operant behaviour, but not on instructed behav-
iour typical in tasks requiring continual responses to
Means (open symbols) and standard deviations (filled sym-bols) of reaction times for a group of boys with ADHD (squares, n = 17) and age-ma ched c ntrol subjects (circles, n = 18) in a 4-choice r ction im  taskFigu 1
Means (open symbols) and standard deviations (filled sym-
bols) of reaction times for a group of boys with ADHD 
(squares, n = 17) and age-matched control subjects (circles, n 
= 18) in a 4-choice reaction time task. The data are from 
Leth-Steensen et al. [52]. The lines through the data derive 
from a series latency mechanism described in the text.Page 5 of 25
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A scheme illustrating a glutamatergic neuron (left) a glial cell (astrocyte) and a small blood vessel (right) and the major compo-nents contribu ing to hypotheses 1 and 2 (H1 and H2)Figur  2
A scheme illustrating a glutamatergic neuron (left) a glial cell (astrocyte) and a small blood vessel (right) and the major compo-
nents contributing to hypotheses 1 and 2 (H1 and H2). Neural activity triggers release of the neurotransmitter glutamate that 
is taken up into the astrocyte (via GLAST and GLT-1 transporters), and stimulates the breakdown of glycogen, the uptake of 
glucose, and glycolysis, to produce lactate. Rapid neuronal firing is sustained by the energy provided by the astrocyte-neuron 
lactate shuttle. Energy demands are high during rapid (burst) and maintained rates of neuronal firing. H1: At times of increased 
neuronal demand, deficient lactate results in decreased neuronal conversion of lactate to acetyl CoA, decreased ATP forma-
tion, deficient ATPase function, delayed restoration of ion gradients, elevated extracellular K+, deficient Na+-dependent trans-
port of glutamate into astrocytes that is required to drive glycolysis and lactate release by the astrocytes. The result is that 
situationally appropriate firing rates are achieved only episodically. Methylphenidate treatment results in an increase of the 
extracellular levels of the catecholamines, NA (and DA) that stimulate glycolysis and release of lactate from the astrocytes. 
This is followed by glycogen replenishment, thereby correcting the energy deficiency, and restoring appropriate firing rates. 
H2: A deficient supply of lactate for oligodendrocytes in the developing nervous system slows and reduces the synthesis of 
fatty acids required for the synthesis of myelin. Poorly myelinated axons would transmit action potentials more slowly, 
accounting for inefficient integration (coherence) between brain regions and for slow reaction times. A number of neurotrans-
mitter receptors present on astrocytes are not illustrated (e.g. muscarinic, α2, DA D3, D4, D5 and receptors for several neu-
ropeptides).
Behavioral and Brain Functions 2006, 2:30 http://www.behavioralandbrainfunctions.com/content/2/1/30rapid, externally-paced stimuli (cf., [68]). Methylpheni-
date medication improves accuracy, speeds reaction time,
and reduces reaction time variability in individuals with
ADHD [35,58]. Moreover, methylphenidate has been
shown to improve time on-task, with concomitant
decreases in the number of shifts in attention as the task
progressed [67]. Such treatment effects suggest that the
increased availability of extra-neuronal catecholamines
arising from the blockade of their uptake by methylpheni-
date could lead to increased activity of noradrenaline at β-
adrenoceptors and possibly also dopamine acting at D1
receptors found on astrocytes [15,69]. A key fact is that
stimulation of α1- and β-adrenoceptors on astrocytes
enhances glycolysis and lactate production [69].
Dopamine acting on D1 receptors may have similar
effects, but these are not well documented.
2.1.5 Existing explanations and their limitations
At present, various tasks used to measure different aspects
of executive function usually have moderately heavy cog-
nitive demands and share requirements for continuous
speeded responding to computer- or experimenter-pro-
duced stimuli, rather than being self-paced. Experimenter-
paced measures of working memory are substantially bet-
ter predictors of reading letter span, continuous operation
span, literacy and mathematics scores than are more tradi-
tional, subject-paced measures [70]. We believe they pro-
vide better diagnostics of ADHD because, like stress tests
for cardiac function, they most directly challenge the sub-
jects' short-term reserves of energy, and that is a major
resource compromised in ADHD.
Slowing of MRT and increasing RT variability over time
has been postulated to reflect mental fatigue, 'resource
depletion', motivational deficits, fluctuations in executive
control, or underlying neurobiological disturbances (e.g.,
motor timing deficits), which are caused by the need for
continuous speeded responding to high-demand tasks
[6,20,71-75]. Most of these models cannot account for the
moment-to-moment fluctuations in response accuracy
characteristic of ADHD.
The dynamic developmental theory of ADHD [8,9,20]
explains intra-individual behavioural variability as defi-
cient acquisition of stimulus control of long chains of
behaviour. This deficiency is rooted in reduced efficacy of
reinforcers ("rewards") combined with poorer extinction
("unlearning") of inefficient behaviour. The dynamic
developmental theory addresses free-operant behaviour
without time constraints. However, neither the dynamic
developmental theory of ADHD, nor other theories and
explanations account for the intra-individual perform-
ance variability of ADHD on tasks that require continual
responses to rapid, externally-paced stimuli. The present
paper addresses this aspect by postulating that reaction
time variability and other manifestations of transient fluc-
tuations in performance, which arise in the context of the
need for continuous rapid neuronal firing, reflect the
effects of transient depletion of neuronal energy on the
efficiency of information processing.
3. The hypothesis
In this section we highlight the strengths and limitations
of Todd and Botteron's Energy-Deficiency Model (section
3.1), present a brief background on astrocytes and their
role in the development and function of the CNS (section
3.2), formulate the hypotheses (H1 and H2: section 3.3),
and provide a detailed summary of evidence supporting
the hypotheses (section 3.4).
3.1 Energy-deficiency model
According to Todd and Botteron [13], the genesis of the
behavioural symptoms of ADHD is linked directly to
impairments of the astrocyte-neuron lactate/energy-shut-
tle that is based on the astrocytic uptake of glucose from
blood capillaries, its utilization (conversion to lactate)
and storage as glycogen [76]. Since acute amphetamine
treatment of young adults has been reported to stimulate
glucose uptake in the frontal lobes [77], Todd and Bot-
teron hypothesized that reduced catecholaminergic input
(in ADHD) leads to a decrease in astrocyte-mediated neu-
ronal energy metabolism and impaired frontal function.
Todd and Botteron's model links catecholaminergic activ-
ity to the regulation of neuronal energy metabolism. But
it does not make explicit how a decreased neuronal energy
supply mediated by hypofunctioning catecholamines
might alter either cognitive performance based on frontal
lobe function or account for ADHD symptomatology in
general. In contrast, our hypothesis addresses a specific
aspect of the clinical presentation, – namely, moment-to-
moment fluctuations in task performance that are often
also manifest in general behaviour – and we refine and
extend the biochemical bases that underlie this hypo-
thesis.
3.2 Astrocyte and oligodendrocyte function in the central 
nervous system (CNS)
The CNS comprises two main types of cells: neurons that
are directly involved in information processing, and glial
cells (astrocytes, oligodendrocytes and microglia) which
play a major role in the development and mature function
of the CNS. Astrocytes are responsible for maintaining the
environment of cells in the CNS: they provide nutrients
and modulate the release and uptake of glutamate, elec-
trolytes (Na+/K+) and other by-products of neural activity
[78]. In addition, astrocytes play an important role in neu-
ral signalling. They have receptors for neurotransmitters
such as glutamate, GABA, acetylcholine and the monoam-
ines as well as for other neuromodulators including neu-Page 7 of 25
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84]. They can modulate the excitability of neurons via
oscillations of Ca2+ levels initiated by stimulation of
metabotropic glutamate receptors [15,85-90].
Oligodendrocytes are responsible for forming myelin, a
membranous sheath that is wound spirally around axons,
providing electrical insulation that leads to a more than
10-fold increase in the speed of signal transmission occur-
ring in unmyelinated axons [11].
3.3 Statement of the hypothesis
Lactate production by astrocytes is insufficient during
brief periods of increased demand in ADHD. This hypo-
thesis has two consequences (Figure 2). H1) The inability
of astrocytes to provide an adequate supply of lactate to
rapidly firing neurons results in a localized and transient
deficiency in ATP production, impaired restoration of
ionic gradients across neuronal membranes and slowed
neuronal firing. This leads to inconsistent performance of
demanding cognitive tasks; H2) Insufficient provision of
lactate for oligodendrocyte function in the longer term
gives rise to deficient fatty acid synthesis and delayed or
reduced myelination of axons. In turn this leads to less
efficient transmission and longer reaction times. The
hypothesis refers to two effects over very different time
scales: The effects on rapidly firing neurons occur over
milliseconds (H1), whereas the effects of reduced lactate
supply for oligodendrocytes when demands are high dur-
ing development takes place over months and years (H2).
Collectively the neural outcomes of astrocyte dysfunction
would manifest behaviourally as inefficient and/or incon-
sistent performance (i.e. slow and/or variable response
times across the lifespan, particularly during tasks that
require continuous speeded responses and complex infor-
mation processing).
3.4 The hypothesis – discussion
3.4.1 H1: Impaired astrocyte function limits energy (lactate) supply 
to rapidly firing neurons
The ionic composition of the cell cytoplasm is very differ-
ent from extracellular ion concentrations. In the neuron
the ionic gradients across the membrane constitute a store
of potential energy that can drive the influx of Na+ and
efflux of K+ ions to generate an action potential, and the
influx of Ca2+ ions to trigger neurotransmitter release and
to generate Ca2+ waves in and between both neurons and
glial cells. To maintain repeated firing over an extended
time, neurons require energy to restore the trans-mem-
brane gradients of Na+, K+ and Ca2+ ions. Neurons gener-
ate the necessary energy in the form of ATP; this drives the
membrane-associated Na+/K+ATPase to pump Na+ out of
the cell and K+ back into the cell. ATP is also required by
Ca2+ATPase to pump Ca2+ out of the cell or into intracel-
lular stores (Figure 2).
Neuronal activity is tightly coupled to glucose utilization
[91]. Neural activity triggers oxidative metabolism (to
produce ATP) within neurons followed by breakdown of
energy stores (glycogen in astrocytes) and uptake of glu-
cose from blood capillaries into astrocytes to produce lac-
tate [91]. Rapid neuronal firing, however, is sustained by
the astrocyte-neuron lactate shuttle [92]. Lactate is the
essential energy source for rapidly firing neurons. It is a
more efficient fuel than glucose because it is metabolized
to form ATP more rapidly and, unlike glucose, does not
require ATP for its metabolism [76]. It is imperative for
neurons to make use of the most efficient energy supplies
when rapid neural processing is required and demands for
energy are high, and the brain has evolved ways to do so
[93]. The neurotransmitter glutamate (released by the
majority of excitatory neurons in the CNS) stimulates gly-
colysis (glucose utilization and lactate production) in
astrocytes and release of lactate into the extracellular fluid
[91,94]. An inadequate supply of lactate during periods of
rapid neuronal firing, when local energy demand is high,
briefly impairs neuronal function, particularly during the
latter part of a train of neural impulses and shortly there-
after, causing an extended refractory period. This
increased latency to new information is measured in the
attentional blink paradigm (section 2.1.3). Compromised
energy supply, as hypothesized for ADHD, should impair
response inhibition or alternation at these times.
Periods of rapid neuronal firing will be followed by slow
unsynchronized firing exerting less demand on energy
resources, allowing replenishment of energy reserves and
restoration of function. Energy reserves will depend on
the prior history of neural and astrocyte activity. Brief peri-
ods of energy insufficiency followed by periods of normal
supply are proposed to account for the variability of
behavioural response seen in ADHD when performing
complex tasks that require speed and accuracy.
3.4.1.1 Impaired maintenance of ion gradients across the neuronal 
membrane
Decreased availability of lactate to produce energy in the
form of ATP would impair the function of membrane-
associated Na+/K+ATPase and Ca2+ATPase pumps, result-
ing in elevated extracellular K+ and decreased Ca2+ and
Na+ concentrations. Consistent with this hypothesis,
ADHD children were reported to have decreased urinary
excretion of Ca2+, Na+ and phosphate, but not K+ ions
[95]. Failure to maintain homeostasis of inorganic ions
will alter electrochemical gradients across neuronal and
glial cell membranes. As the resting membrane potential
of neurons is dominated by the K+ concentration gradient
across the membrane, failure to reduce elevated extracel-
lular K+ concentrations following neural activity will alter
membrane potentials, cause depolarization to last longer
than required, and thus impair neuronal function. RaisedPage 8 of 25
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effects in different parts of the brain, promoting for exam-
ple monoamine release (e.g. dopamine [96]) and altering
the conformation of transporters, thus affecting monoam-
ine uptake (e.g. dopamine [97] 5-HT [98]).
3.4.1.2 Impaired uptake and removal of extracellular glutamate
Astrocytes normally maintain low extracellular levels of
glutamate and K+ [78]. Glutamate transport into astro-
cytes is driven by the influx of Na+ along its electrochemi-
cal gradient. But the low membrane potential resulting
from the astrocytes being less able to maintain low extra-
cellular K+ concentrations in the ADHD condition will
diminish the electromotive drive for Na+ influx and
thereby hamper removal of glutamate from the extracellu-
lar fluid [93,99,100]. Failure to maintain low extracellular
glutamate levels will impair glutamate neurotransmitter
function, neuroplasticity, learning and memory, and
could lead to excitotoxicity and cell death, reflected as
reduced CNS gray matter. (Small reductions in grey matter
are reported for subjects with ADHD [101-103]).
3.4.1.3 Impaired neuromodulator regulation of lactate formation
Several neurotransmitters can potentially modulate lac-
tate production in astrocytes, with the majority of evi-
dence supporting a role for noradrenaline acting on α1-,α2- and β-adrenoceptors [88,104-106]. This is important
in view of widely accepted explanations of ADHD symp-
toms in terms of catecholamine function [107], psychos-
timulant effects on glucose utilization (section 3.1) and
efficacy as medication [108]. Glial receptors for dopamine
(D1–5) [15,88] and serotonin (5-HT2) [109] have also
been reported but their effects on lactate production in
astrocytes have not been well documented.
Extracellular lactate decreases immediately after neuronal
activation, but rises again after a short delay [110]. Nor-
mally within milliseconds of glial β- or α2-adrenoceptor
activation noradrenaline induces the breakdown of glyco-
gen to glucose (glycogenolysis) to supply the needed lac-
tate [69,105,111,112]. This is followed by a phase of
glycogen re-synthesis in the astrocytes that can last several
hours [112]. Failure to adequately replenish glycogen
stores in the astrocytes would reduce the availability of
energy substrates required for subsequent or sustained
neuronal activity. Therapeutic agents (e.g. methylpheni-
date, amphetamine, atomoxetine, desipramine,
modafinil) block the noradrenaline transporter and
increase extracellular concentrations of noradrenaline
which stimulates glycolysis and lactate production in
astrocytes. Although evidence strongly supports a role for
noradrenaline, both dopamine and serotonin are known
to modulate cAMP levels in astrocytes and could therefore
also play a role [15,109].
Glucocorticoid hormones also modulate the supply of
energy [113,114]. Glucocorticoids inhibit glucose trans-
port into neurons and astrocytes and inhibit glycogen syn-
thesis stimulated by noradrenergic activity [115]. Thus,
glial activity may be down-regulated by increased hypoth-
alamo-pituitary-adrenal activity in situations perceived as
stressful (e.g. expressed emotion in the family of ADHD
children or the challenge provided by cognitive tasks pre-
sented to the children). High levels of glucocorticoids act-
ing on astrocytes would impair glycogen replenishment,
deplete energy reserves, and reduce lactate transport.
Behaviourally, this will give rise to fatigue and predispose
to psychological problems, as has been proposed for other
disorders such as Parkinsonism and major depression
[116].
Cytokines, small proteins that support communication
between cells of the immune system, can be produced by
and influence the function of astrocytes (e.g. TNF-alpha,
IL-1, IL-6 [117]). Reduced stimulation of β-adrenoceptors
leads not only to decreased glycogenolysis but also to
impaired production of several growth factors (e.g. nerve
growth factor (NGF), basic fibroblast growth factor (basic
FGF), transforming growth factor-beta1 (TGF-beta1)
along with increased production of nitric oxide and the
pro-inflammatory cytokines [118,119]. Cytokine expo-
sure can lead to an overproduction of nitric oxide and its
metabolites that diffuse out and damage mitochondria
and the energy supply in nearby cells (including neurons
[120]). TNF-alpha and IL-1 can fundamentally perturb the
energy metabolism of astrocytes promoting the uptake of
glucose without either storing it as glycogen or releasing
lactate [121]. This disruption can therefore not only
impair short-term demands for energy, but also the long-
term requirements for development (see hypothesis H2,
section 3.4.3), that in the worst case can lead to apoptosis
of the oligodendrocyte [118]. Other cytokines (e.g. the
calcium-binding S100B) also regulate energy metabolism,
promote neuronal survival and regeneration [122].
Dopamine also stimulates release of growth factors
(including NGF, glial-derived nerve growth factor, GDNF
and brain-derived nerve growth factor, BDNF) and there-
fore plays a crucial role in development of the brain and
maturation of the nervous system [84].
3.4.2 Preliminary evidence: impaired energy supply during rapid 
neuronal firing in ADHD
This section first considers the limited direct neuroimag-
ing evidence of altered energy utilization in the CNS of
people with ADHD that could potentially derive from
deficient astrocyte function [116]. We then discuss elec-
troencephalographic (EEG) recordings indicating ineffi-
cient communication within and between neuron clusters
that could be attributed to impaired energy supplies.Page 9 of 25
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tive challenge of CPT performance was measured by posi-
tron emission tomography (PET) and deoxyglucose in 25
adults with childhood onset of ADHD [123]. The authors
reported decreases in utilization in 30 of 60 regions ana-
lysed, and a global reduction of >8%. The largest decreases
were registered in adjacent regions of the superior frontal,
premotor, and somatosensory cortices. Methylphenidate
in healthy volunteers has been shown to increase glucose
utilization in these and other brain regions (e.g. cerebel-
lum), perhaps by elevating extracellular noradrenaline
concentrations. Decreased glucose utilization in ADHD
may result from inadequate noradrenergic stimulation of
astrocytes. But decreased glucose utilization in striatum
and differences following acute vs. chronic methylpheni-
date treatment are results that warn against making simple
generalizations about the effects of stimulants on energy
utilization [124].
Some EEG measures indicative of ADHD may reflect
impaired immediate energy supply from astrocytes (H-1)
and others impaired myelination (H-2, section 3.4.3/4)
deriving from a longer-term lactate deficiency. In either
case the presence or absence of effort to overcome the
inefficiency should be visible in terms of the amplitude of
event-related potential (ERP) components in the EEG rep-
resenting the stages of information processing, and defi-
cient levels of 'activation' in the ERP latencies.
The contingent negative variation (CNV) is an excitatory,
slow, negative-going waveform that occurs in the second
before a stimulus. The CNV is usually considered to index
anticipatory and preparatory processes to a stimulus that
may require a response. It has been reported to be reduced
in amplitude in people with ADHD [125-127], although
this was not replicated in two further reports [128,129].
The extent to which the reduction of CNV reflects reduced
effort in or motivation for preparation is secondary to the
point at issue here, namely that subjects with ADHD are
poorly prepared for the stimulus. This may be due to
impaired learning, or poor association of actions with
delayed outcomes in previous experiences, as suggested by
Sagvolden et al. [20], and this is non-adaptive to the
demands of the situation. The P3 component elicited by a
rare or meaningful stimulus represents updating of work-
ing memory-like templates of its associations. The ampli-
tude is reduced in most studies of ADHD. It has been
argued that reduced effort makes a contribution to this
effect [130,131]. These are two of several ERP markers
reflecting inefficient information processing in ADHD.
We propose that insufficient energy reserves underlie this
deficiency.
Variable ERP latencies are widely reported, especially for
the P3. This variability is evident in 8–9 year-old children
born very prematurely and given the diagnosis of ADHD,
compared to those who had a similarly low birth weight
without the ADHD diagnosis [132]. Methylphenidate
treatment decreased variability both of the P3 component
[133,134] and the response times recorded [135,136].
The number of responses that were too early (premature,
impulsive) or too late were reduced with psychostimulant
treatment [135,137]. Effective therapeutic drugs blocked
dopamine and noradrenaline transporters and increased
extracellular levels of catecholamines permitting activa-
tion of β-adrenoceptors (and/or D1 receptors) on astro-
cytes to stimulate lactate production.
3.4.3 H2. Impaired oligodendrocyte function impairs axon 
myelination
In the human brain the myelination of axons – a principle
function of the oligodendrocytes – starts in utero and con-
tinues through the first 3–4 decades of life [138]. The
increase of white matter during development puts high
demands on metabolism. Myelin starts to form before
birth with much being laid down in the first two years of
life. Myelination is prominent in the prefrontal cortex,
and of course in the major fibre tracts, especially the cor-
pus callosum – with levels of "adult functionality"
achieved normally during adolescence [139,140].
Impaired myelin synthesis as a result of intermittently
insufficient lactate production by astrocytes would have a
detrimental effect on the coordinated myelination of
axons during development, and lead to impaired commu-
nication between brain regions and poor integration of
information in these target brain structures.
Oligodendrocytes normally oxidise glucose and lactate at
far higher rates than either neurons or astrocytes [14,141].
Glucose is metabolised in the pentose phosphate pathway
to produce NADPH and in the glycolytic pathway to pro-
duce lactate, both of which are used to synthesize lipids:
lactate is the preferred substrate for fatty acid synthesis
and myelin formation. As oligodendrocytes are the high-
est lactate and glucose consumers in the developing brain,
any deficiency in the supply of lactate would impair lipid
synthesis and retard myelination of axons. Impaired mye-
lination reduces the speed of conduction of action poten-
tials in individual neurons and could account for slow
reaction times. Axons that are not properly insulated by
the myelin sheath would be less efficient at conducting
action potentials and require more energy resources than
normal. Partial myelination of fibre pathways would also
contribute to impaired integration of information in tar-
get regions and provide a further source of response vari-
ability.
Myelination is a sensitive indicator of functional brain
maturation. Across at least the first two decades of devel-
opment myelination consists of a broad increase in over-Page 10 of 25
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progression, proceeding from posterior to more anterior
regions, [142-145]. In magnetic resonance spectroscopy
(MRS) and diffusion tensor imaging (DTI) studies, matu-
ration of relatively restricted regions of white matter has
been found to correlate with the development of cognitive
functions such as working memory capacity (left frontal
regions), reading ability (left temporal lobe) and even
with IQ (bilateral association areas [144,146]. In a study
of 100 children with evidence of delayed development
but otherwise normal MR-scans, Pujol and colleagues
[143] were able to show a reduction of myelination (in
part asymmetric) equivalent to normally developing chil-
dren who were some 3 years younger. Also, at the other
end of the lifespan, white matter damage due to axonal
loss that occurs in normal ageing has been found to corre-
late with working memory performance, even after con-
trolling for age [19]. This suggests that working memory
performance may be particularly dependent on complex
networks, which in turn depend upon white matter con-
nections. These studies conclude that there is a positive
relationship between the density and organization of
myelinated fibres and the efficiency (maturity) of cogni-
tive function [144].
3.4.4 Preliminary evidence of altered myelination in ADHD
3.4.4.1 Neuroimaging
Evidence for impaired and/or delayed myelination
derives from MR measures of white matter density and the
integrity of myelinated neuronal pathways indexed by
DTI and MRS measures of metabolites (e.g. N-acetyl-
aspartate, NAA). Support for the functional impairment of
these pathways comes from EEG recordings (section
3.4.4.2).
Seven of the 8 anatomical MRI studies report decreased
total white matter volumes in children and adolescents
with ADHD [102,103,147-150]. In the largest MRI study
that scanned over 150 boys with ADHD on at least two
separate occasions, the reduction in white matter volume
was substantial (a 10% reduction) compared to those
who had been treated with stimulant medication or had
no diagnosis [103]. Indeed, one study linked smaller
white matter volumes with slower processing speed, as
indexed by the speed of colour-naming [150]. These
results implicate a contribution of delayed myelination to
ADHD cognition.
DTI provides a measure (fractional anisotropy, FA) of the
coherence and integrity of the biochemical microstructure
of myelinated pathways. An initial study comparing a
group of 18 children with ADHD with 15 matched con-
trols recorded a reduced FA in the right cerebral peduncle/
anterior limb of the internal capsule (right neostriatum
and premotor cortex), and in the left middle cerebellar
peduncle (left cerebellum and parieto-occipital region).
Ashtari and colleagues report that the lower the cerebellar
FA, the more severe were the ratings of symptoms of inat-
tention [151]. These first findings point to a link between
white matter anomalies and the symptomatology of
ADHD.
Such findings are extended by 1H-MRS measures of neu-
ronal metabolism in the brains of subjects with ADHD.
With this method creatine, choline, taurine, inositol,
NAA, glutamate and lactate can be detected and meas-
ured. Unfortunately there have been scant attempts to
report on the last two. As yet creatine, choline (and their
phospho-derivatives) – regarded as indicators of lipid
metabolism and membrane integrity – have also not been
studied in ADHD. The easiest metabolite to measure is
NAA. NAA is found in neurons, not in glia, and is regarded
as a marker of neuronal density, function, viability and
perhaps functional connectivity [152]. It is synthesised by
the enzyme NAA transferase in neuronal mitochondria
from acetyl coenzyme A (acetyl Co-A) and aspartate, and
used by oligodendrocytes to produce acetyl groups for the
synthesis of myelin lipids [153,154]. During development
NAA levels increase (as choline levels fall) and reflect
increased synthesis (or decreased utilization) in the for-
mation of myelin [155,156]. High NAA concentrations
correlate with increased ADP [157,158] as acetyl CoA lev-
els required for ATP synthesis are depleted. Decreases of
NAA levels reflecting neuronal dysfunction are associated
with neuronal loss in certain parts of the brain in many
major psychiatric illnesses [159].
Increased NAA levels are reported for the right frontal lobe
[160] and fibres entering/leaving left frontal regions (cen-
trum semi-ovale [161]) of ADHD subjects compared to
healthy and autistic comparison groups. But group differ-
ences were not found in 2 studies of the right frontal lobe
[162,163] and decreases were reported in small studies for
the left frontal [164] and right lenticular regions [165].
However Yeo et al. [162] noted that the smaller right fron-
tal volume for their 17 ADHD children correlated with
NAA and choline measures, and that NAA levels in turn
related to performance on a sustained attention task. Else-
where, intriguingly, raised frontal glutamate concentra-
tions were noted, particularly on the right [160,163]. As a
cautionary note, it should be pointed out that animal
work has shown that methylphenidate treatment can lead
to increased cortical levels of NAA [166]. Further, the
results of these 6 ADHD studies must be regarded as pre-
liminary as they each represent very small subject groups,
and the range of brain regions they could sample was very
restricted. Nonetheless it should be noted that all the
studies recorded changes, and unusually some subjects
show raised metabolite levels (NAA, choline, glutamate).
These results point to changed patterns and rates of mye-Page 11 of 25
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tently insufficient supplies of lactate. The result is an
overall decrease of white matter for a given age-class, as
described above.
3.4.4.2 Neurophysiology
We propose that the functional consequences of the
impaired/delayed developmental laying down of the
myelin sheath can be seen in three types of EEG measure:
evoked potential (EP) latencies, the topographic distribu-
tion of the power spectrum in the quantitative EEG, and
in the coherence of the EEG waveforms between brain
regions.
EPs representing sensory information ascending in the
auditory nerve [167] and the brain stem appear at longer
than normal latencies (e.g., components III and V).
Indeed, the transmission times from components I to III
and I to V are reported to be increased in subjects with
ADHD [168]. The latency of the steady state visual EP in
the frontal cortex of ADHD children is markedly delayed
[169]. Indeed, in their report of a delayed velocity index
for EPs in ADHD, Ucles et al [170] proposed not only that
abnormal myelination in the cortico-spinal path could be
responsible, but that the result could be indicative of a
much more widespread problem.
A large proportion of patients with ADHD (or narcolepsy,
see 3.5.1 below) demonstrate an increased ratio of relative
theta to alpha or beta power in the EEG, especially over
anterior brain regions [171,172]. One explanation of the
dominant lower firing frequencies could lie with the
reduced lactate availability required to sustain rapidly fir-
ing neurons. There is usually a marked normalization of
this balance between oscillation frequencies after methyl-
phenidate treatment [173]. In the unmedicated sample
there is a positive correlation between P2, N2 and P3 ERP
latencies, widely reported to be delayed [137] and
increased theta power [174,175]. A plausible reason for
this shift in balance between oscillation frequencies lies in
a decreased representation of the faster frequencies owing
to deficient neuronal energy supply (H1) and/or reduced
myelination in brain stem reticular sources active in gen-
erating some of these rhythms [170] which is consistent
with our hypothesis H2.
A more direct measure of the coupling of activity between
brain regions can be estimated by EEG coherence of wave-
form between recording sites. Coherence can be conceptu-
alised as the correlation in the time domain between 2
signals in a given frequency band. EEG coherence nor-
mally develops systematically with age in a non-linear
fashion. There is evidence of development in longer-range
inter-hemispheric coherences which are not apparent in
boys with ADHD. Furthermore, boys with ADHD show
elevated slow-wave coherences and reduced fast-wave
coherences between hemispheres, although within hemi-
spheres the coherence in the theta band is reduced, espe-
cially over frontal regions [176-178]. This is most easily
explained by unusual if not delayed development of the
large white matter tracts connecting brain regions. At
short distances between signals the increased coherence at
slow wave frequencies in children with ADHD is viewed
as consistent with a delay in the pruning back of over-pro-
duced synapses and local connections [179]. As would be
expected such long-term alterations remain unaffected by
short-term methylphenidate treatment [180].
3.5 Supportive evidence from related disorders
We propose that a disturbed lactate shuttle in ADHD
accounts for brief transient impairments in rapid neuro-
nal firing and delayed myelination: Together they result in
variable responses. These impairments may account for
similar phenomena in other neurodevelopmental disor-
ders. We do not regard our hypothesis as specific to
ADHD – for example, individuals with schizophrenia
have been found to respond more slowly and variably on
attentional and cognitive tasks [181,182] – nor do we sug-
gest that it occurs in all psychiatric disorders. In the fol-
lowing sections we select two disorders, PKU and
narcolepsy, to illustrate the presence of phenomena that
appear to model the situation that pertains to ADHD.
3.5.1 Parallel pathological conditions: Phenylketonuria (PKU)
PKU results from high concentrations of phenylalanine
(Phe), that arise from an inability to convert it into tyro-
sine, and which inhibit transport across the blood brain
barrier of neutral amino acids such as tyrosine and tryp-
tophan necessary for the synthesis of the three principle
monoamine transmitters. If children are placed on Phe-
free diet early enough, microcephaly, mental retardation
and motor problems can be avoided, although sub-clini-
cal symptoms may remain, particularly in the cognitive
domain [183,184]. Children with PKU (off-diet) are rated
by parents and teachers as more distractible, hyperactive,
and impulsive than healthy controls [185], with many
symptoms similar to ADHD (e.g. restlessness, fidgeting,
concentration difficulty, short attention span, low frustra-
tion tolerance [186]). Realmuto et al. [187] noted that 9/
13 of their subjects either manifested or had a history of
comorbidity with ADHD. Prenatal exposure was associ-
ated with a higher likelihood of expressing hyperactive/
impulsive symptoms and postnatal exposure was associ-
ated with a higher likelihood of expressing inattentive
symptoms [188]. Indeed, a considerable proportion of
people with treated PKU take psychostimulant medica-
tion for their attentional problems (e.g. 26% of a sample
of 38 school-aged children with PKU [189]).Page 12 of 25
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with ADHD include variable reaction times, sustained
attention, working memory, executive function, planning,
learning, tests of colour-naming, arithmetic, verbal abili-
ties and academic performance [187,190-199]. Inter-
hemispheric interactions, as measured by slowed transfer
times [200], and a lack of the across-hemisphere advan-
tage in performing a name-identity task [183], are affected
in comparison to neurologically intact children. Neuro-
physiological studies report slow latencies for several early
EPs [201], the later P3 component and slower more vari-
able motor reaction times [194,195,202]. In the EEG slow
(theta) rhythms are characteristic of individuals with
PKU. Indeed their high theta/alpha ratio (recalling
ADHD) was sensitive to treatment reducing the levels of
Phe [203,204].
Functionally, these features reflect delayed myelination,
low monoamine levels, and impaired energy availability.
Impaired myelination is the primary neuropathological
feature of treated or untreated people with PKU: A delay is
typical of the younger ages and diffuse demyelination is
reported at older ages [205-208]. The finding of low HVA
levels (dopamine metabolite) in the CSF [209] confirms
the second feature, low dopamine levels. Importantly,
changes of dopamine in the rodent model go hand in
hand with the depletion and restoration of Phe levels
[210]. Noradrenaline and serotonin would also be
expected to be affected. The third feature was addressed in
11 young adults with PKU using phosphate MRS. Pietz et
al. [204] describe changes of cerebral energy metabolism
that could underlie reduced transmission speed, myelina-
tion and catecholamine availability [205]. Among 11
measures taken at baseline, only ADP was significantly
elevated, and inorganic phosphate decreased. Phe loading
then decreased phosphocreatine and ATP levels while fur-
ther increasing ADP. This is consistent with Phe inhibition
of pyruvate kinase and the concurrent conversion of ADP
to ATP [211]. Impaired pyruvate synthesis would reduce
lactate production and the ability of astrocytes to meet the
energy requirements of sustained rapid neural firing and a
shortage of lactate would also impair the ability of oli-
godendrocytes to synthesize myelin.
3.5.2 Parallel pathological conditions: narcolepsy
Narcolepsy is a neurological disorder characterized by
excessive daytime sleepiness [212]. Some of the neuropsy-
chological characteristics of narcolepsy are strikingly sim-
ilar to those seen in ADHD and children with ADHD have
an increased tendency to daytime sleepiness [213]. Indi-
viduals with narcolepsy have slower reaction times and
more within-task variability of performance than control
subjects on a variety of attentional tasks ranging from
those sensitive to arousal and sustained attention, to the
executive control of attention [214]. Recent studies report
narcolepsy-related deficits in attentional and executive
function which place high demands on inhibition and
task management, but not on simple tasks of memory and
attention [214,215]. The pattern of findings was thought
to be indicative of a depletion of available cognitive
processing resources because of the need for continuous
allocation of resources to monitoring.
Like ADHD, hypoarousal (sleepiness) is induced in situa-
tions of low stimulation, such as reading or boring repet-
itive tasks [112,216-218]. Similarly, children with ADHD
or narcolepsy appear to use motor overactivity and fidget-
iness to counteract their drowsiness [218-220]. It is inter-
esting to speculate how a deficiency in energy supply
might contribute to the other symptoms of ADHD, such
as hyperactivity. Depression of sensory modules could
certainly lead to a suboptimal level of stimulation, induc-
ing sensation-seeking behaviour, with motor, vocal, and
other activities displacing the contextually "appropriate"
behaviours, which through local energy deficiency can no
longer provide the necessary arousal. Derangements of
calcium-dependent protein phosphatase and kinase activ-
ity impair working memory [221]. These and other impli-
cations of the energetics hypothesis require further
consideration, lying beyond the scope of this paper.
Lastly, as in ADHD analyses, EEG rhythms show the ratio
of theta to alpha or beta power in narcolepsy to be higher
than normal [172]. Narcolepsy has been attributed to
depletion of the transmitter hypocretin, a hypothalamic
neuropeptide that regulates energy metabolism and
dopamine activity in certain brain regions [222-224].
Modafinil, the drug normally used to treat narcolepsy, is
effective in treating ADHD and can inhibit dopamine re-
uptake [220,225-228]. It is also an α1-adrenoceptor ago-
nist and can therefore facilitate β-adrenoceptor-stimu-
lated lactate production in astrocytes [229,230]. Thus, the
mechanism of treatment could be the same in both disor-
ders. This highlights the similarities between the disorders
that could reflect common underlying disturbances.
4. Testing the hypotheses
The fundamental tenet of our hypotheses (H-1 and H-2)
– to be tested – is that a deficient energy supply to rapidly
firing neurons (the lactate shuttle) underlies moment-to-
moment fluctuations in response speed and accuracy
(astrocyte mechanisms) and, in the long-term, episodes of
lactate deficiency during development delays axon myeli-
nation (oligodendrocyte function). These two links need
to be demonstrated (section 4.1).
The consequences of these disturbances are proposed to
lie with a) decreased neural activity when sustained rapid
firing is required (neurophysiological level), b) delayed
and variable cohesion between the components of the
neural circuitry responsible for integration of informationPage 13 of 25
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chophysiology), and c) the poorly coordinated and intra-
individual variability of performance typical of individu-
als with ADHD. More evidence is required (section 4.2).
4.1 Is there an energy deficiency?
There are several points in the energy cycle where dysfunc-
tion could occur. The present hypothesis focuses on one
specific aspect: The provision of adequate amounts of the
more efficient metabolic fuel, lactate (rather than glu-
cose), to rapidly firing neurons (e.g. glutamate trans-
porter, mitochondria, monoaminergic regulation of
astrocyte function: section 4.1.1). Identification of envi-
ronmental and/or genetic origins of the lactate deficiency
would contribute to an understanding of intra-individual
variability in performance of high energy-demanding
tasks (section 4.1.2). Factors that impair myelination may
contribute to slow responsiveness and are also reviewed
(section 4.1.2).
4.1.1. The performance of energetic compartments
There is a need for more precise measures of the dynamics
within and between the major compartments of energy
production, storage and utilization through studies using
labelling, stimulation and inhibition of the various con-
stituents in animal models of ADHD and tissue culture
(e.g. delineation of the quantitative relationship between
neuronal firing rate and lactate utilization, intra/extracel-
lular glutamate flow, mitochondrial function (ATP/ADP
ratio and oxygen consumption), effects of lactate restric-
tion on ionic gradients, function of regulatory factors (e.g.
neurotransmitter/neuropeptide receptors, particularly
noradrenergic α1-, α2- and β-adrenoceptors), effect of
impaired lactate production on myelin synthesis (and
accumulation of NAA), influence of NAA availability on
acetyl-group incorporation into myelin). Regional differ-
ences in measures of effects of transient energy deficiency
are important to note, since the hypothesis does not pre-
dict that all parts of the brain will be affected equally.
Greater effects (e.g. reduced size) should be observed in
those brain areas that contain or form part of rapidly fir-
ing neural circuits that transiently deplete local energy
reserves and hinder synapse formation.
Measures of some of these effects are becoming techni-
cally feasible for human studies, in vivo, with MRS. For
example, changes in glutamate production (tricarboxylic
acid cycle), lactate synthesis (glycolysis) and glutamine
synthesis have been demonstrated in neurological
patients using labelled carbon (13C) MRS [231,232]. Fur-
ther data on the energy metabolites ATP, ADP, inorganic
phosphate, phosphocreatine and creatine obtained from
more conventional proton and phosphate MRS studies
would also be useful (cf. section 3.5.1). A second example
is based on the changes of intracellular calcium oscilla-
tions and extracellular calcium waves generated by neuro-
transmitter stimulated glia. These calcium signals
stimulate glutamate release, modulate neuronal excitabil-
ity and carbohydrate metabolism [86,89]. Changes in cal-
cium concentration can be monitored by new contrast
substances being developed for MRI investigations. These
techniques, and recent applications of 2-photon optical
calcium imaging in animals, could also address the role of
dopamine D1 and D2 receptors [233] as well as metabo-
tropic glutamate receptors and their modulation by α1-
adrenoceptors in the stimulation of calcium responses in
astrocytes [85,234,235]. A third example is the need for
cross-sectional if not longitudinal MRS data on myo-
inositol. This is suggested to be a marker of the integrity of
glia and glial transport mechanisms, but the signal has
proved difficult to separate from that for the large
amounts of glycine present that also resonate at 3.6 ppm
[236]. Whereas increased levels of myo-inositol are
claimed to reflect gliosis that would not be expected in
ADHD, decreased levels, as reported for major depressive
disorder, may reflect glial loss or altered glial metabolism
[237]. Indeed a functional decrease may apply to ADHD.
A preliminary report on 15 subjects with ADHD found an
increased glutamate/myo-inositol ratio [238], that would
be consistent with either increased extracellular glutamate
concentrations or an inadequate supply of myo-inositol.
4.1.2 Origins of a putative energy and lipid deficiency
The principle claim of our hypothesis, that lactate produc-
tion and availability is impaired, may be difficult to meas-
ure directly in human subjects, but may be best tested
with a pharmacological challenge in animal models of
ADHD such as the spontaneously hypertensive rat (SHR)
[239,240] and poor (and impulsive) performers on the 5-
choice serial reaction time task that show low 2-deoxyglu-
cose uptake (index of brain glucose uptake) in the cingu-
late and ventrolateral orbital cortices during performance
of the visuospatial task [241]. Lactate production should
be recorded at baseline, during performance of the task,
and after methylphenidate, atomoxetine or venlafaxin
treatment (transport inhibitors of the three monoam-
ines). The effect of pretreatment with monoamine recep-
tor antagonists could also be investigated. The link
between performance, energy availability and at least
some of these treatments should be established. Other
cognitive tests that make use of dynamic strategies
(change in contingency) can be used to evaluate possible
correlation between changes in lactate production/utiliza-
tion and performance speed/accuracy.
Glutamate availability for uptake into astrocytes and stim-
ulation of lactate production requires special attention.
Impaired release would reduce astrocytic lactate synthesis.
The impairment could lie with SNAP-25, a protein impor-
tant for the release of the transmitter. There is some evi-Page 14 of 25
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SNAP-25 gene and ADHD [242,243]. A potential relation-
ship to energy production should be investigated. Lactate
synthesis is dependent on glutamate uptake into astro-
cytes. Problems with glutamate transport could give rise to
deficient lactate synthesis. Metabotropic glutamate recep-
tor function and the glutamate/aspartate transporter
(GLAST) have been suggested to play a role the develop-
ment of fatigue [78,244]. To test this hypothesis, gluta-
mate metabolism could be measured in astrocytes of
animal models of ADHD using an experimental setup that
simulates the role of neurons (glutamate producers and
glutamine consumers) by the addition of glutaminase to
the culture medium [245]. A steady supply of glutamate
can be imposed at the expense of glutamine, and the stress
intensity manipulated by changing the glutaminase con-
centration [246]. The extracellular concentration of gluta-
mate will provide information on the efficiency of flux
through the glutamate transporter and glutamine syn-
thetase system in restoring the extracellular concentration
of glutamate to a low level [247]. This will provide a meas-
ure of the glutamate drive of lactate formation.
More quantification of developmental changes in myeli-
nation in ADHD, using sensitive neuroimaging tech-
niques such as DTI, MRS, EEG or MEG would be
informative. More simply, for indications of impaired
white matter generation blood samples should be taken
from healthy children and those with ADHD to investi-
gate lipid availability (serum fatty acid levels and the
nature of red blood corpuscle membranes). This approach
has been useful in showing changes in patients with schiz-
ophrenia and depression (e.g. reduced polyunsaturated
fatty acids like arachidonic and docosahexaenoic acid
[246,247], decreased linoleic acid [248], less high-density
lipoprotein levels [249]). An early report on hyperactive
children suggested there were slightly decreased levels of
poly-unsaturated, but increased levels of saturated fatty
acids [250]. Chen et al. [251] found decreased nervonic
acid, linoleic acid, arachidonic acid, and docosahexaenoic
acid in red blood cell membranes of children with ADHD
while plasma gamma-linolenic acid and red blood cell
oleic acid were increased. Irmisch noted a potential rela-
tionship with stress experienced by their subjects [250]. As
glucocorticoids modulate membrane stability and the
adrenal hormone dehydroepiandrosterone influences
lipid synthesis, both steroids should be monitored in the
recommended study [252] (section 3.4.1.3). The availa-
bility of these fatty acids (particularly of the omega series),
as well as marked prostaglandin synthesis (e.g. cyclooxy-
genase) around puberty are crucial determinants of syn-
apse modification, pruning and maturation processes
[253] that may be delayed in ADHD. These studies would
usefully supplement further delineation of the fibre bun-
dles that are [254] or in ADHD are not showing normal
developmental increases of anisotropy studied with DTI.
Of the numerous potential genetic sources of the modifi-
cation of energy availability, we would select those that
regulate lactate metabolism (lactate, glutamate and glu-
cose transporters, glycogen synthase, glycogen phosphor-
ylase, glycolytic enzymes), factors that regulate glutamate
release from synaptic terminals and hence glutamate-
stimulated lactate production (e.g. SNAP25, vesicle trans-
porter, metabotropic glutamate receptors, adenosine A1
receptors, neurexins, factors that regulate intracellular
Ca2+), and astrocyte function (e.g. noradrenergic α1, α2
and β-adrenoceptors, dopamine D1 receptors). Mito-
chondrial function should also be considered, as impair-
ment of gene transcription can occur through the
accumulation of mitochondrial DNA mutations [255].
One potential candidate is Ant1, a mitochondrial ATP/
ADP exchanger that facilitates efflux of ATP out of the
mitochondria and glutamate uptake into astrocytes [256].
Metabotropic glutamate receptors are of special interest as
stimulation can produce marked Ca2+ oscillations. Its
expression represents a glial sensor of the extracellular
glutamate concentration that can be used to acutely regu-
late excitatory transmission [257].
Likewise, there are many genetic influences on lipid syn-
thesis and myelin formation of potential relevance to our
hypothesis on oligodendrocyte function in ADHD. We
select but one for attention. Lingo-1 is expressed in oli-
godendrocytes and is critical for CNS myelin formation.
Treatment of neuron and oligodendrocyte cell culture
with soluble Lingo-1 (a transmembrane protein binding
to the Nogo-66 receptor/p75 signaling complex) led to
highly developed and differentiated axons [258,259]. In
animal studies it appears that its up-regulation may be a
characteristic of activity-induced neural plasticity
responses [260]. Thus, its impaired expression could be a
feature of several developmental disorders. We would also
advocate the initiation of microarray studies of gene
expression in samples taken from subjects with ADHD.
This large scale profiling technique applied to patients
with schizophrenia has already shown a surprising
number of genes related to energy metabolism, oli-
godendrocyte function and myelin formation that are
associated with psychopathology [261].
4.1 Neurophysiological and behavioural consequences of 
an energy deficiency
Neuroimaging techniques reflecting glucose or oxygen
utilization would be well-suited to examine the effect of
cognitive challenges on glycogen, glucose or lactate utili-
zation (e.g. PET with deoxyglucose, near-infra-red spec-
troscopy of oxygenated/deoxygenated haemoglobin
[262,263]). To what extent do task manipulations (event-Page 15 of 25
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tial responsiveness according to these measures in within-
subject designs with symptomatic and asymptomatic
individuals?
Similar task manipulations should be used during EEG
monitoring of sustained neuronal firing and connectivity
(EP latencies, theta/beta ratios and the coherence between
sites of signal processing). Do people with ADHD show
an early onset of fatigue or feel that they exert undue effort
to overcome the deficiencies across a period of task per-
formance? Skin conductance records would provide an
independent reference for changes in the level of activa-
tion. However, analyses should carefully consider issues
that could mask clear-cut associations such as the different
types of oscillation pattern and the sub-diagnosis often
encountered in an ADHD population [264,265]. Baseline
measures should then be compared with the effects of
medication and carbohydrate loading.
One test of energy deficiency would be based on the lac-
tate and glucose dependency of the neurophysiological
spike activity underlying LTP [266], the basis of short-
term working memories often poorly expressed in ADHD
(section 2.1). Animal work has shown that LTP, engen-
dered in models of ischemic conditions, is amplified by
dopamine D1 action on the AMPA (but not the NMDA)
component of LTP [267]. Would ADHD subjects with a
demonstrable lactate shuttle impairment show improved
working memory following psychostimulant induced
dopamine D1 stimulation of AMPA function?
A behavioural approach could also be applied. Under
high cognitive demand (e.g. the incompatible conditions
of asynchronous flanker tasks) energy requirements are
high and stored resources limited. Mental effort and
energy mobilization may be measured via blood glucose
levels and cardiovascular function [268]. Even though the
measures are relatively simple, they are yet likely to be
associated with the variability of performance over time
and be capable of modification by agents that modify
monoamine transporter function. Support for this predic-
tion derives from a report on two cases of spino-cerebellar
ataxia. The authors describe a strong association between
PET measures of decreased glucose utilization, SPECT
measures of reduced dopamine transporter binding in the
putamen and poor performance on tests of executive func-
tion [269].
5 Implications of the hypothesis
5.1 Implications for basic research
Although it is not possible to state which brain areas will
be affected by restricted energy (lactate) supply, those
with the highest energy demands are more likely to be
affected and may be reduced in size [93]. In support of
this implication of the hypothesis, numerous studies have
found reduced brain volume in people with ADHD, par-
ticularly prefrontal cortex, cerebellum, corpus callosum,
and basal ganglia, areas of the brain engaged in informa-
tion processing and planning/selecting the appropriate
behavioural response [102,103,147,270].
The hypothesis H1 implies that people with ADHD may
develop strategies to overcome their inability to fully uti-
lize the more efficient lactate shuttle during periods of
high energy demand, i.e. extended high frequency neuro-
nal firing. In order to avoid catastrophic depletion of
localized energy reserves, a strategy may have evolved dur-
ing development to avoid prolonged high-frequency fir-
ing of neural circuits by switching to other neural circuits
that produce behaviours that may help to complete the
task. When required to focus and concentrate on perform-
ing a specific task, their behaviour is automatically
switched to other circuits. The advantage of this strategy
may be that they explore the environment more actively
and appear to learn more quickly initially, but they fail to
learn new rules when the contingency changes because of
their inability to stay on task. This may cause the individ-
ual with ADHD to appear easily distracted, because of rap-
idly switching from one task to another to avoid highly
localized depletion of energy reserves. Evidence to sup-
port this suggestion is provided by clinical studies. In both
Norwegian and South African populations of children
with ADHD, Aase, Meyer and Sagvolden [8,9,271] dem-
onstrated increased intra-individual variability of spatial
location of motor responses, independent of accuracy of
performance and time on task (greater spatial variability
but not greater temporal variability because there were no
external time demands placed on participants), suggesting
that sensory-motor reflexes were not as efficient as in con-
trols, possibly because of impaired energy supply to rap-
idly firing neurons in cortico-striatal and/or cortico-
cerebellar circuits. Impaired maintenance of high neuro-
nal firing rates due to suboptimal ATP production would
impair learning at all levels of neural circuits involved in
memory formation, including prefrontal cortex, striatum,
cerebellum, and parietal cortex. Variability of spatial loca-
tion would engage different neural circuits and may reflect
a strategy developed to overcome the problem of insuffi-
cient lactate reserves to meet demands of prolonged rapid
neuronal firing. Variability persists into adulthood
[272,273]. The apparent remission of symptoms in many
adults may be due to their elaboration of a set of redun-
dant processing elements, and the neural procedures for
their seamless engagement, which provide alternative
task-relevant procedures lacking in children.
The hypothesis H1 implies that myelinated and unmyeli-
nated axons will be affected differently. Non-myelinated
axons are less efficient than myelinated axons and we pre-Page 16 of 25
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ciency. Interestingly this would target non-myelinated
nigrostriatal, mesocortical and mesolimbic dopamine
projections, among others, which would affect the devel-
opment of their target structures including striatum, pre-
frontal cortex and hippocampus. Compromised
dopamine neuronal firing could account for decreased
dopamine function in target areas as proposed by
Sagvolden et al [20] in the dynamic developmental theory
of ADHD. Drugs used to treat ADHD, such as methylphe-
nidate, block the dopamine transporter and can thereby
enhance the dopamine signal without requiring increased
firing of dopamine neurons.
A further critical implication of the hypothesis H1 is that
therapeutic drugs should directly or indirectly stimulate
lactate production by astrocytes.
5.2 Implications for theories of ADHD
The current hypothesis extends existing theories of ADHD
by proposing a physiological basis for specific aspects of
the ADHD phenotype – namely frequent, transient and
impairing fluctuations in functioning, particularly during
performance of speeded, effortful tasks. We briefly point
to the interfaces and overlaps.
One proposal attributes many features of ADHD to prob-
lems with the regulation of 'state' that affects the alloca-
tion of 'energy' and 'effort' [274,275]. Based on the
"cognitive-energetic" model of Sanders [276] they define
state regulation as the allocation of extra effort to defend
performance in the presence of stressors such as high pres-
entation rates of stimuli. Whereas CNS activation nor-
mally increases with event-rates, long inter-event intervals
engender a sub-optimal hypoactivation in people with
ADHD, who then are unable to recruit the necessary effort
to adjust appropriately to the demands of the situation.
Activation can be viewed as a state of readiness in selec-
tively targeting possible outcomes of behaviour: The mon-
itoring of input, endogenous interactions and feedback
are involved. Effort is viewed as a process necessary for
coupling and re-coupling input-information, neuronal
modules and activational processes [277]. Our hypothesis
is broadly consistent with this 'state-regulation' theory,
but elaborates details of its potential physiological basis,
and that in turn is specifically directed to account for
intra-individual variability of performance on sustained
demand. The distinction with our formulation lies with a)
our emphasis on coping with high energy demands rather
than a state of hypoactivation at low event-rates, and b)
our prediction that the consequences of impaired lactate
shuttle function lie with reduced rapid neuronal firing
when that is required, and the delayed development of
myelination. We do not predict a generalized 'state of acti-
vation' as described by Sergeant and van der Meere
[274,275].
Barkley (1997) considers symptoms of ADHD to arise
from the disruption of neurocognitive control. Like Bar-
kley we have selected top-down, executive processes for
special but not exclusive consideration. We emphasise
intra-individual variability in the control of the mainte-
nance or switching of set appropriate to adaptive plan-
ning, and behavioural organization towards reasonable
goals. Barkley, however, views these brain-behaviour rela-
tions to be mediated fully by inhibitory processes. Our
hypothesis is not so restrictive, and thereby questions the
centrality of inhibitory processes to ADHD. What Barkley
sees as inhibition we see as a failure of activation, for
which we provide a specific mechanism.
Our hypothesis overlaps with the explanations offered by
Sonuga-Barke [278] and Sagvolden et al. [20]. Sonuga-
Barke's dual pathway theory invokes a role for the mesocor-
tical dopamine system in modulating (deficient) dorsal
fronto-striatal glutamatergic mediation of some executive
functions. It also envisages a role for the mesolimbic
dopamine system in the anomalously functioning reward
and motivation-influencing circuits of the more ventral
frontal-accumbens glutamatergic system [107]. The mes-
olimbic role is often associated with the preference of
ADHD subjects for immediate rather than delayed
rewards. This relates to the dynamic developmental the-
ory of Sagvolden et al., which concentrates on the registra-
tion of reinforcement and related motivational
consequences, in particular, a mesolimbic impairment of
the "efficiency with which the contingency between
present action and future rewards is signalled". In ADHD
research there is widespread agreement that there is a
reduction in the control by future rewards of current
behaviour, and an increase in the extent to which they are
discounted (i.e., a steeper delay of reward gradient).
Sagvolden et al. also extend their theory to impaired func-
tion of the ascending nigrostriatal and mesocortical
dopamine pathways.
Both theories are driven by interpretations of the relative
success of the psychostimulants in terms of dopamine
function as a neurotransmitter, and the need to explain
responsivity to reinforcement in ADHD in a wider moti-
vational context. To a degree the explanations are success-
ful. But we would shift emphasis in our interpretation.
The first shift is clearly from a neurotransmitter interpre-
tation of psychostimulant function to the additional role
of glial stimulation. The second shift concerns the empha-
sis on the role of delay periods. Our hypothesis views
these as requiring the operation of attentional and work-
ing memory components of executive function. Typically
such delays require consistent firing of prefrontal neuronsPage 17 of 25
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degree our emphasis on impaired function under high
demands is consistent with Sonuga-Barke's description of
impaired efficiency of mesocortical dopamine control of
fronto-striatal circuits, and Sagvolden's description of the
difficulty for children with ADHD to comply with (the
demanding) shallow reinforcement gradients. According
to our hypothesis, the reinforcement contingency is not so
much a causal factor in ADHD, as it is an occasion in
which the mechanisms we have outlined are likely to be
operative. People with ADHD will tend to go "off-task"
independent of the reinforcement lost because the effort
to remain "on-task" requires energy resources that are no
longer available to them.
5.3 Implications for ADHD in the clinic
Impaired performance is expressed mainly in tasks of high
temporal and/or cognitive demand and will be less appar-
ent in self-paced tasks of low complexity. Proposals for
modifying current treatment methods can be made at the
behavioural and the biochemical level. Segmenting tasks
to reduce concurrent demands for speed and accuracy of
responding would be helpful in situations that place high
and prolonged demands on neural activity (function).
One possibility is to introduce frequent variation into the
nature of the task or its modality in order to allow for a re-
distribution of the energetic demands to alternate neural
processing circuitry. A second possibility is to introduce
frequent breaks into ongoing, lengthy and demanding
activities such as school exams, assembly lines and motor-
way driving. Both strategies would permit energetic
demands to be distributed to alternate resources and the
re-establishment of depleted energy reserves. A third
method is the institution of self-paced rather than system-
paced scheduling of the required activity. Each strategy
would reduce concurrent demands for both the speed and
accuracy of performance during continuous and complex
information processing tasks. Also, if speed and accuracy
are required in a complex task, a third possibility is to
reduce the cognitive demands by segmenting the task into
smaller and simpler steps, with breaks between steps.
Investigations of potential therapeutic agents that target
the energetic system rather than neurotransmitter func-
tion may yield additional improvements in treatment
beyond the positive modulation of the energy balance
noted for monoaminergic drugs in current use. One aim
could be to stimulate creatine kinase function, and thus to
increase the availability of phosphocreatine, and the re-
synthesis of ATP. Increasing creatine levels would have the
additional advantage of being neuroprotective [280].
While there is clearly a need to restore carbohydrate and
energy reserves and to ensure an adequate supply of
omega fatty acids and other elements essential for myelin
synthesis, it is equivocal whether dietary supplementation
is capable of delivering the requisites to where they are
needed. In the longer term it may prove more feasible to
modify the expression of genes demonstrated to be essen-
tial in the regulation of astrocyte function, lactate produc-
tion, glutamate transport and myelin synthesis [261].
Several novel forms of therapeutic agent and delivery sys-
tem based on the components of the energy cycle and the
synthesis of myelin could be tested.
6 Abbreviations
Acetyl CoA acetyl coenzyme A





CNS central nervous system
CNV contingent negative variation
CPT continuous performance test








1H-MRS proton magnetic resonance spectroscopy
ISD individual standard deviation
K+ potassium ions
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
MRT mean reaction timePage 18 of 25
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RT Reaction time, or response time
SD standard deviation
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